Cargando…

PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma

OBJECTIVE: This study aimed to explore PLEK2 expression profile, its prognostic value, and the potential genomic alterations associated with its dysregulation in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). MATERIALS AND METHODS: Data from The Cancer Genome Atlas (TCGA), The G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wenqian, Li, Tong, Hu, Bin, Li, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588770/ https://www.ncbi.nlm.nih.gov/pubmed/33084541 http://dx.doi.org/10.1177/1533033820957030

Ejemplares similares

The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer
por: Gu, Yi, et al.
Publicado: (2018)

GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma
por: Liu, Xun, et al.
Publicado: (2019)

Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis
por: Zhao, Man, et al.
Publicado: (2023)

The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma
por: Shioya, Akihiro, et al.
Publicado: (2018)

Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor
por: Watanabe, Kousuke, et al.
Publicado: (2018)

PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway
por: Shen, Hui, et al.
Publicado: (2019)

The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma
por: Kawatsu, Y, et al.
Publicado: (2014)

Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment
por: Tseng, Jeng-Sen, et al.
Publicado: (2018)

Impaired Liver Function Implied Shorter Progression Free Survival for EGFR Tyrosine Kinase Inhibitors
por: Zhu, Qi-Qi, et al.
Publicado: (2018)

Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma
por: Chen, De, et al.
Publicado: (2018)

Cognitive impairments are independently associated with shorter survival in diffuse glioma patients
por: van Kessel, Emma, et al.
Publicado: (2020)

KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma
por: Saglam, Ozlen, et al.
Publicado: (2020)

Transcriptome Profiling of Whole Blood Cells Identifies PLEK2 and C1QB in Human Melanoma
por: Luo, Yuchun, et al.
Publicado: (2011)

Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis
por: Wang, Jingyun, et al.
Publicado: (2021)

PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway
por: Liu, Yang, et al.
Publicado: (2021)

PLEK: a tool for predicting long non-coding RNAs and messenger RNAs based on an improved k-mer scheme
por: Li, Aimin, et al.
Publicado: (2014)

Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies
por: Christopoulos, Petros, et al.
Publicado: (2021)

Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients
por: Marczynski, Gabriella Taques, et al.
Publicado: (2020)

Visceral Obesity Is Associated with Shorter Progression-Free Survival in Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Neoplasia
por: Santos, Ana P., et al.
Publicado: (2022)

A High MCM6 Proliferative Index in Atypical Meningioma Is Associated with Shorter Progression Free and Overall Survivals
por: Gauchotte, Guillaume, et al.
Publicado: (2023)

Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma
por: He, Chenglu, et al.
Publicado: (2021)

Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma
por: Liu, Xi, et al.
Publicado: (2018)

Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival
por: Katayama, Daisuke, et al.
Publicado: (2021)

Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma
por: He, Xia, et al.
Publicado: (2019)

hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance
por: Wadi, Suzan, et al.
Publicado: (2016)

TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2
por: Wang, Feng, et al.
Publicado: (2021)

MNX1 facilitates the malignant progress of lung adenocarcinoma through transcriptionally upregulating CCDC34
por: Wu, Junhua, et al.
Publicado: (2023)

Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes
por: Yin, Ji-bin, et al.
Publicado: (2020)

Upregulation of NDUFAF2 in Lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker
por: Zou, Kang, et al.
Publicado: (2023)

Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
por: Yang, Shih-Hung, et al.
Publicado: (2017)

Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survival
por: Courtwright, Andrew M., et al.
Publicado: (2020)

Lung Transplant Candidates With Pretransplant Gastroesophageal Reflux and Antibodies to Lung Self-antigens Have Shorter CLAD-free Survival After Transplant
por: Razia, Deepika, et al.
Publicado: (2022)

Stenotrophomonas maltophilia promotes lung adenocarcinoma progression by upregulating histone deacetylase 5
por: Shen, Jiyu, et al.
Publicado: (2023)

High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer
por: Yang, Yi, et al.
Publicado: (2018)

PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c‐Myc‐mediated positive feedback loop
por: Zhao, Xinyuan, et al.
Publicado: (2022)

AIM2 upregulation promotes metastatic progression and PD‐L1 expression in lung adenocarcinoma
por: Zheng, Jing‐Quan, et al.
Publicado: (2022)

Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy
por: Kou, Fan, et al.
Publicado: (2022)

Expression of ANO1/DOG1 is associated with shorter survival and progression of breast carcinomas
por: Bae, Jun Sang, et al.
Publicado: (2017)

PLEK2, RRM2, GCSH: A Novel WWOX-Dependent Biomarker Triad of Glioblastoma at the Crossroads of Cytoskeleton Reorganization and Metabolism Alterations
por: Kałuzińska, Żaneta, et al.
Publicado: (2021)

Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches
por: Yang, Xia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_54ddun2pceivufu0dp6bp71n45